Immune checkpoint inhibitors are a class of immunotherapy drugs that block proteins used by cancer cells to evade immune detection, effectively “releasing the brakes” on the immune system. Common agents target PD-1, PD-L1, or CTLA-4 pathways, treating cancers such as melanoma, lung, and bladder cancers. Treatment requires close monitoring for immune-related side effects, with oncologists tailoring therapy to maximize benefit and minimize risks.
2025 Bangkok Prices
Checkpoint Inhibitors: THB 250,000–800,000 per cycle depending on drug and indication
Includes immune profiling, drug administration, and side effect management
Delivered by expert oncologists in specialized immune-oncology centers using latest protocols.